Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Quest Diagnostics Sells OralDNA Labs to Access Genetics

By LabMedica International staff writers
Posted on 01 Jan 2013
Quest Diagnostics (Madison, NJ, USA), a provider of diagnostic information services, has sold substantially all of the assets of its OralDNA Labs salivary-diagnostics business to Access Genetics (Eden Prairie, MN, USA), a clinical laboratory with molecular diagnostics test development and information technology capabilities. More...
The terms of the transaction were not disclosed. This will allow Quest to refocus its resources on its core diagnostic information services business for physicians and hospitals.

Since 2008, Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals. As part of the transaction, OralDNA's testing services, now provided from a facility in Brentwood, TN (USA) will consolidate under Access Genetic's Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP)-certified laboratory in Eden Prairie, MN (USA).

Quest Diagnostics offers broad access to diagnostic information services through its network of laboratories and patient service centers, and provides consultation services through its medical and scientific staff.

Access Genetics provides web-based software, laboratory materials, and networked expertise to improve molecular diagnostics and patient care. The company offers comprehensive solutions to physicians including pathologists, and clinical laboratories for molecular (DNA-based) testing through a web-based Molecular Information System (TeleGene).

Related Links:
Quest Diagnostics
Access Genetics


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.